New functions of glucosamine as a scavenger of the lipid peroxidation product malondialdehyde

Chemical Research in Toxicology

Volumn 20, Issue 6, 2007, Pages 947-953

  Fang, Chui ^a   Peng, Mijun ^a   Li, Guolin ^a   Tian, Jinzhou ^a   Yin, Dazhong ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE; GLUCOSAMINE; LIPID; LIPOFUSCIN; MALONALDEHYDE;

ARTICLE; CHEMICAL REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH; SPECTROFLUOROMETRY; SPECTROPHOTOMETER;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUORESCENCE; FREE RADICAL SCAVENGERS; GLUCOSAMINE; HYDROGEN-ION CONCENTRATION; LIPID PEROXIDATION; MALONDIALDEHYDE; MASS SPECTROMETRY; MOLECULAR STRUCTURE; PROTEIN CARBONYLATION; SPECTROMETRY, FLUORESCENCE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

BOVINAE;

EID: 34447115159     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700059b     Document Type: Article

References (53)

1. Tiku, M. L., Shah, R., and Allison, G. T. (2000) Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J. Biol. Chem. 275, 20069-20076.
2. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
3. Janero, D. R. (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol. Med. 9, 515-540.
4. Dalle-Donne, I., Giustarini, D., Colombo, R., Rossi, R., and Milzani, A. (2003) Protein carbonylation in human diseases. Trends Mol. Med. 9, 169-176.
5. Urso, M. L., and Clarkson, P. M. (2003) Oxidative stress, exercise and antioxidant supplementation. Toxicology 189, 41-54.
6. Yin, D., and Chen, K. (2005) The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp. Gerontol. 40, 455-465.
7. Requena, J. R., Fu, M. X., Ahmed, M. U., Jenkins, A. J., Lyons, T. J., and Baynes, J. W. (1997) Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem. J. 322, 317-325.
8. Baynes, J. W., and Thorpe, S. R. (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48, 1-9.
9. Yin, D. (1996) Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radical Biol. Med. 21, 871-888.
10. Kikugawa, K., Tsukuda, K., and Kurechi, T. (1980) Studies on peroxidized lipids. Interaction of malondialdehyde with secondary amine and its relevance to nitrosamine formation. Chem. Pharm. Bull. 28, 3323-3331.
11. Tiku, M. L., Allison, G. T., Karishma, N., and Karry, S. K. (2003) Malondialdehyde oxidation of cartilage collagen by chondrocytes. Osteoarthritis Cartilage 11, 159-166.
12. Hamerman, D. (1989) The biology of osteoarthritis. N. Engl. J. Med. 320, 1322-1330.
13. Kempson, G. E., Muir, H., Pollard, C., and Tuke, M. (1973) The tensile properties of the cartilage of human femoral condyles-related to the content of collagen and glycosaminoglycans. Biochim. Biophys. Acta 297, 465-472.
14. Hollander, A. P., Pidoux, I., Reiner, A., Rorabeck, C., Bourne, R., and Poole, A. R. (1995) Damage to type II collagen in aging and osteoarthritis starts at articular surface originates around chondrocytes, and extends into the cartilage with progressive degeneration. J. Clin. Invest. 96, 2859-2869.
15. Ala-Kokko, L., Baldwin, C. T., Moskowitz, R. W., and Prockop, D. J. (1990) Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc. Natl. Acad. Sci. U.S.A. 87, 6565-6568.
16. Fassler, R., Schnegelsberg, P. N., Dausman, J., Shinya, T., Muragaki, Y., and McCarthy, M. T. (1994) Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc. Natl. Acad. Sci. U.S.A. 91, 5070-5074.
17. Verzijl, N., DeGroot, J., Oldehinkel, E., Bank, R. A., Thorpem, S. R., and Baynesm, J. W. (2000) Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem. J. 350, 381-387.
18. DeGroot, J., Verzijl, N., Budde, M., Bijlsma, J. W., Lafeber, F. P., and TeKoppele, J. M. (2001a) Accumulation of advanced glycation end products decreases collagen turnover by bovine chondrocytes. Exp. Cell Res. 266, 303-310.
19. DeGroot, J., Verzijl, N., and Marion, J. G. (2004) Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum. 50, 1207-1215.
20. Houpt, J. B., McMillan, R., Wein, C., and Paget-Dellio, S. D. (1999) Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J. Rheumatol. 26, 2423-2430.
21. D'Ambrosio, E., Casa, B., Bompani, R., Scali, G., and Scali, M. (1981) Glucosamine sulfate: a controlled clinical investigation in arthrosis. Pharmacotherpeutica 2, 504-508.
22. Institute of Medicine and National Research Council. (2004) Prototype monograph on glucosamine. In Dietary Supplements: a framework for evaluating safety. C-1-C-86.
23. Xing, R., Liu, S., Guo, Z., Yu, H., Li, C., and Ji, X. (2006) The antioxidant activity of glucosamine hydrochloride in vitro. Bioorg. Med. Chem. 14, 1706-1709.
24. Kikugawa, K., and Beppu, M. (1987) Involvment of lipid oxidative products in the formation of fluorescent and cross-linked proteins. Chem. Phys. Lipids 44, 277-296.
25. Felson, D. T., Lawrence, R. C., Dieppe, P. A., Hirsch, R., Helmick, C. G., and Jordan, J. M. (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann. Intern. Med. 133, 635-646.
26. Weightman, B. O., Freeman, M. A., and Swanson, S. A. (1973) Fatigue of articular cartilage. Nature 244, 303-304.
27. DeGroot, J., Verzijl, N., Bank, R. A., Lafeber, F. P., Bijlsma, J. W., and TeKoppele, J. M. (1999) Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum. 42, 1003-1009.
28. DeGroot, J., Verzijlm, N., Jacobs, K. M., Budde, M., Bank, R. A., and Bijlsma, J. W. (2001b) Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthritis Cartilage 9, 720-726.
29. Poli, G., and Parola, M. (1997) Oxidative damage and fibrogenesis. Free Radical Biol. Med. 22, 287-305.
30. Yin, D. (1992) Lipofuscin-like fluorophores can result from reactions between oxidized ascorbic acid and glutamine. Carbonyl-protein crosslinking may represent a common reaction in oxygen radical and glycosylation-related ageing processes. Mech. Ageing Dev. 62, 35-45.
31. Glantz, S. A. (1981) Primer of Biostatistics. New York: McGraw-Hill Press, p. 352.
32. Nair, V., Cooper, C. S., Vietti, D. E., and Turner, G. A. (1986) The chemistry of lipid peroxidation metabolites: crosslinking reactions of malondialdehyde. Lipids 21, 6-10.
33. Xu, D., Thiele, G. M., Kearly, M. L., Haugen, M. D., Klassen, L. W., and Sorrell, M. F. (1997) Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme linked immunosorbent assay. Chem. Res. Toxicol. 10, 978-986.
34. Tuma, D., Thiele, G., Xu, D., Klassen, L., and Sorrell, M. (1996) Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 23, 872-880.
35. Li, G., Li, L., and Yin, D. (2005) A novel observation: Melatonin's interaction with malondiadehyde. Neuro. Endocrinol. Lett. 26, 61-66.
36. Li, L., Li, G., Sheng, S., and Yin, D. (2006) Substantial reaction between histamine and malondialdehyde: A new observation of carbonyl stress. Neuro. Endocrinol. Lett. 26, 799-805.
37. Kang, Z., Li, H., Li, G., and Yin, D. (2006) Reaction of pyridoxamine with malondialdehyde: Mechanism of inhibition of formation of advanced lipoxidation end-products. Amino Acids 30, 55-61.
38. d'Ischia, M., Napolitano, A., and Costantini, C. (1995) Reactions of malondialdehyde with amine neurontransmitters. Formation and oxidation chemistry of fluorescent 1,4-dihydropyridine adducts. Tetrahedron 51, 9501-9508.
39. Itakura, K., and Uchida, K. (2001) Evidence that malondialdehyde-derived aminoenimine is not a fluorescent age pigment. Chem. Res. Toxicol. 14, 473-475.
40. Itakura, K., Uchida, K., and Osawa, T. (1996) A novel fluorescent malondialdehyde-lysine adduct. Chem. Phys. Lipids 84, 75-79.
41. Chio, K. S., and Tapple, A. L. (1969) Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry 8, 2821-2826.
42. Thorpe, S. R., and Baynes, J. W. (1996) Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 9, 69-77.
43. Slatter, D. A., Murray, M., and Bailey, A. J. (1998) Formation of a dihydropyridine derivative as a potential cross-link derived from malondialdehyde in physiological systems. FEBS Lett. 421, 180-184.
44. Li, G., Li, H., Wang, B., and Yin, D. (2006) Effects of malondialdehyde on growth and proliferation of human bone marrow mesenchymal stem cells in vitro. Front. Biol. Chi. 1 131-136.
45. Yin, D. (1995) Studies on age pigments evolving into a new theory of biological aging. Gerontology 41, 159-172.
46. Lindsay, R. M., Altar, C. A., Cedarbaum, J. M., Hyman, C., and Wiegand, S. J. (1993) The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp. Neurol. 124, 103-118.
47. Piccoli, F., and Riuggeri, R. M. (1995) Dopaminergic agonists in the treatment of Parkinson's disease: a review. J. Neural. Transm. Suppl. 45, 187-195.
48. Varughese, G. I., Patel, J. V., Lip, G. Y., and Varma, C. (2006) Novel concepts of statin therapy for cardiovascular risk reduction in hypertension. Curr. Pharm. Des. 12, 1593-1609.
49. Luo, J. D., and Chen, A. F. (2003) Perspectives on the cardioprotective effects of statins. Curr. Med. Chem. 10, 1593-1601.
50. Baynes, J. W. (2001) The role of AGE in aging: causation or correlation. Exp. Gerontol. 36, 1527-1537.
51. Goodnick, P., and Gershon, S. (1984) Chemotherapy of cognitive disorders in geriatric subjects. J. Clin. Psychiatry. 45, 196-209.
52. Hipkiss, A. R. (2000) Carnosine and protein carbonyl groups: a possible relationship. Biochemistry. 65, 771-778.
53. Wang, A. M., Ma, C., Xie, Z. H., and Shen, F. (2000) Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry 65, 869-871.